RORC expression is lower in patients with SLE compared to healthy individuals, suggesting an imbalance in immune regulation, particularly in the interaction between IL-23 and STAT3, which may influence clinical symptoms and treatment outcomes in SLE (El-Karaksy et al., 2016; Kluger et al., 2017). The gene discussed is STAT3; the disease is systemic lupus erythematosus.